FeelGood GLP-1 2026 Research Explores Brand-Stated $149/Month Telehealth Access, Compounded Medication Disclosures, and Buyer Questions Why This Review Exists Right Now - and Why Timing Matters for GLP-1 Buyers in 2026 FDA has publicly identified concerns involving unapproved and compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent compounded products, adverse-event reports, semaglutide salt forms, and illegal online sales
doi: 10.1074/jbc.M300755200 33 Fairweather-TaitSJCollingsRHurstR
Prescribing these medications for brain protection alone would be off-label, and the human evidence is not strong enough to justify it outside of trial settings
As such, patients incur those costs indefinitely
Slower results allow your body to adjust properly and preserve muscle mass